Protecting patient access to discounted medications and health care services through Washington's health care safety net by preventing manufacturer limitations on the 340B drug pricing program.

Summary

The bill bars pharmaceutical manufacturers and their agents from refusing or restricting the sale of discounted 340B drugs to safety‑net providers or their contract pharmacies in Washington. It also stops manufacturers from demanding data as a condition for providing those drugs. Violations can be sued in civil court with daily fines, and the state attorney general may enforce the rule.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share